People seeking treatment for opioid addiction are often denied appointments
Researchers have discovered a troubling trend while looking into why so many addicts go without treatment in America.
As part of a study that covered the areas of the U.S. with the highest rates of overdose-related deaths, scientists discovered that about 40 percent of providers were unable or unwilling to provide an appointment to seek treatment. Even more concerning, the number of denied appointments was higher for people who were on Medicaid, which applies to "nearly 4 in 10" adults with an opioid addiction in the U.S., The Associated Press reported.
To conduct their research, two callers posed as adult heroin users, calling over 500 clinics in Maryland, Massachusetts, New Hampshire, Ohio, West Virginia, and the District of Columbia. The study, published on Monday in the Annals of Internal Medicine, paints a dire picture for opioid addicts who are trying to get help.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
As for the difference between being uninsured and relying on Medicaid, while 38 percent of the calls were denied for people paying in cash, 46 percent were denied for Medicaid patients. It may be that "doctors have room in their schedules, but are shunning Medicaid because it pays less than other insurance," AP explained.
"I found it surprising how many calls I had to make before being offered an appointment," said Tamara Beetham, one of the researchers who conducted the calls. The number of calls and the frequency of being turned away can be a deterrent to people seeking addiction treatment, which makes this study a troubling revelation for people struggling with addiction across the country. Read more at The Associated Press.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Shivani is the editorial assistant at TheWeek.com and has previously written for StreetEasy and Mic.com. A graduate of the physics and journalism departments at NYU, Shivani currently lives in Brooklyn and spends free time cooking, watching TV, and taking too many selfies.
-
Political cartoons for January 10Cartoons Saturday’s political cartoons include a warning shot, a shakedown, and more
-
Courgette and leek ijeh (Arabic frittata) recipeThe Week Recommends Soft leeks, tender courgette, and fragrant spices make a crisp frittata
-
Trump’s power grab: the start of a new world order?Talking Point Following the capture of Nicolás Maduro, the US president has shown that arguably power, not ‘international law’, is the ultimate guarantor of security
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
A fentanyl vaccine may be on the horizonUnder the radar Taking a serious jab at the opioid epidemic
-
Nitazene is quietly increasing opioid deathsThe explainer The drug is usually consumed accidentally
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
The UK’s opioid crisis: why the stats don’t add upThe Explainer A new report has revealed that the UK’s total of opioid-related deaths could be much greater than official figures show
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses